Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Leukemia|January 4, 2020
CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapyRoss Kinstrie, Gillian A Horne, Heather Morrison, et al.Leukemia|February 2, 2020
Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapyRoss Kinstrie, Gillian A Horne, Heather Morrison, et al.EMBO Reports|July 25, 2023
Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cellsKevin M Rattigan, Martha M Zarou, Zuzana Brabcova, et al.Nature Communications|August 17, 2023
Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cellsKevin M Rattigan, Zuzana Brabcova, Daniele Sarnello, et al.Blood|February 14, 2018
hsa-mir183/EGR1-mediated regulation of E2F1 is required for CML stem/progenitor cell survivalFrancesca Pellicano, Laura Park, Lisa E M Hopcroft, et al.Nature|June 10, 2016
Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cellsSheela A Abraham, Lisa E M Hopcroft, Emma Carrick, et al.Leukemia|September 7, 2018
Targeting quiescent leukemic stem cells using second generation autophagy inhibitorsPablo Baquero, Amy Dawson, Arunima Mukhopadhyay, et al.Nature Communications|February 5, 2024
Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow nicheAmy Dawson, Martha M Zarou, Bodhayan Prasad, et al.Pageof 2